PER-090-04已完成未知
MULTICENTER, RANDOMIZED, DOUBLE-BLIND, WITH DOUBLE SIMULATION, OF PARALLEL GROUPS, STUDY TO EVALUATE THE EFFECTIVENESS OF VALSARTAN 320 MG / HYDROCHLOROTHIAZIDE 12.5 MG VERSUS ENALAPRIL 20 MG / HYDROCHLOROTIZIDE 12.5 MG ON THE MEDIUM SYSTOLIC ARTERIAL PRESSURE IN POSITION SITTED IN PATIENTS WITH HYPERTENSION MODERATE
OVARTIS BIOSCIENSES PERU S.A.,0 个研究点目标入组 0 人开始时间: 2005年2月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of both sexes> 18 years of age
- •Mean SBP> 160 mmHg in Visits 1 and 2, for untreated patients. Patients who are receiving antihypertensive medication in Visit 1 should not have their blood pressure controlled (ie, mean BP> 140/90 mmHg). By treated patients are meant those patients who take medication up to 2 days before Visit 1
- •All patients must have a PASMS> 160 mmHg at Visit 3.
排除标准
- •PASMS> 180 mmHg and / or PADMS> 110 mmHg at any time between Visit 1 and Visit 3.
- •History of hypertensive encephalopathy, stroke, ischemic attack
- •Percutaneous coronary intervention (PCI), or Myocardial Revascularization Surgery.
- •Diabetes mellitus type 2 uncontrolled, ie HbA1c> 8.5%
研究者
相似试验
进行中（未招募）
1 期
A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INTRAVENOUS CR845 IN HEMODIALYSIS PATIENTS WITH MODERATE-TO-SEVERE PRURITUS, WITH A 52-WEEK OPEN-LABEL EXTENSIOEUCTR2018-001930-17-CZCara Therapeutics INC350
已完成
不适用
MULTICENTER, DOUBLE-BLIND, RANDOMIZED, DETERMINATION STUDY OF THE RANGE OF DOSE TO COMPARE THE SAFETY AND ACTIVITY OF MK-0518 PLUS TENOFOVIR AND LAMIVUDINE (3TC) COMPARED TO EFAVIRENZ PLUS TENOFOVIR AND LAMIVUDINE (3TC) IN PATIENTS INFECTED WITH HIV NOT SUBMITTED TO ART- EXTENSION STUDY-B24 Unspecified human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseB24PER-054-08MERCK SHARP & DOHME PERU S.R.L.,
已完成
不适用
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving ChemotherapyPER-078-05GLAXOSMITHKLINE PERU S.A.,
进行中（未招募）
不适用
MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, TWO-ARM PARALLEL GROUPS STUDY DESIGN TO DEMONSTRATE THE EFFICACY AND TOLERABILITY OF A SINGLE DOSE OF BDP SUSPENSION FOR NEBULISATION 1600 mcg VS PLACEBO IN THE TREATMENT OF CHILDREN AGED 6 MONTHS TO 3 YEARS WITH A CLINICAL DIAGNOSIS OF MODERATE CROUP - NDEUCTR2009-014376-22-ITCHIESI
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, DOUBLE BLIND, DOUBLE-DUMMY PLACEBO- CONTROLLED PARALLEL-GROUP MULTIPLE DOSE STUDY OF THE EFFICACY AND SAFETY OF TACROLIMUS INHALATION AEROSOL IN PATIENTS WITH MODERATE PERSISTENT ASTHMA - Tacrolimus MDI Dose ResponseModerate persistent asthmaMedDRA version: 7.0Level: LLTClassification code 10003555EUCTR2004-001075-20-LTFujisawa GmbH400